Related Experiment Videos
Pericarditis induced by high-dose cytarabine therapy.
Archives of Internal Medicine
|September 1, 1984
Summary
High-dose cytarabine treatment for acute lymphocytic leukemia can cause pericarditis with tamponade. This serious cardiac complication appears to be a direct result of the chemotherapy regimen.
Area of Science:
- Oncology
- Cardiology
- Hematology
Background:
- Acute lymphocytic leukemia (ALL) is a rapidly progressing cancer of the blood and bone marrow.
- High-dose cytarabine is a chemotherapy agent commonly used in the treatment of ALL.
- Pericarditis and cardiac tamponade are potential, though rare, complications in cancer patients.
Observation:
- A patient undergoing high-dose cytarabine therapy for acute lymphocytic leukemia developed pericarditis.
- The patient subsequently experienced cardiac tamponade, a life-threatening condition where fluid accumulates in the pericardium, compressing the heart.
Findings:
- The clinical presentation strongly suggests that the pericarditis with tamponade was a direct complication of the high-dose cytarabine treatment.
- This adverse event highlights a specific cardiotoxicity associated with this chemotherapy regimen.
Implications:
- Clinicians should be vigilant for cardiac complications, including pericarditis and tamponade, in patients receiving high-dose cytarabine for ALL.
- Further research may be warranted to elucidate the precise mechanisms of cytarabine-induced cardiotoxicity and to develop preventative or management strategies.